Cargando…

Management of Implantable Cardioverter-Defibrillators during Pregnancy—A Systematic Review

Background: With the advent of implantable cardioverter-defibrillator (ICD) technology in recent decades, patients with inherited or congenital cardiomyopathy have a greater chance of survival into adulthood. Women with ICDs in this group are now more likely to reach reproductive age. However, pregn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Topf, Albert, Bacher, Nina, Kopp, Kristen, Mirna, Moritz, Larbig, Robert, Brandt, Mathias C., Kraus, Johannes, Hoppe, Uta C., Motloch, Lukas J., Lichtenauer, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069958/ https://www.ncbi.nlm.nih.gov/pubmed/33919684 http://dx.doi.org/10.3390/jcm10081675

Ejemplares similares

Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
por: Topf, Albert, et al.
Publicado: (2021)

Subcutaneous administration of levothyroxine: a novel approach to refractory hypothyroidism – A review and a case report
por: Topf, Albert, et al.
Publicado: (2021)

Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
por: Topf, Albert, et al.
Publicado: (2022)

The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
por: Topf, Albert, et al.
Publicado: (2021)

The Value of Fetuin-A as a Predictor to Identify Takotsubo Patients at Risk of Cardiovascular Events
por: Topf, Albert, et al.
Publicado: (2021)

Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
por: Topf, Albert, et al.
Publicado: (2022)

Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
por: Jirak, Peter, et al.
Publicado: (2022)

Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
por: Topf, Albert, et al.
Publicado: (2022)

The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
por: Topf, Albert, et al.
Publicado: (2020)

Exercise-related T-wave oversensing: an underestimated cause of reduced exercise capacity in a pacemaker-dependent patient—a case report and review of the literature
por: Topf, Albert, et al.
Publicado: (2020)

Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis
por: Mirna, Moritz, et al.
Publicado: (2021)

Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
por: Mirna, Moritz, et al.
Publicado: (2021)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction
por: Kopp, Kristen, et al.
Publicado: (2023)

Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute Myocarditis
por: Mirna, Moritz, et al.
Publicado: (2022)

Intraoperative Defibrillation Testing of Subcutaneous Implantable Cardioverter‐Defibrillator Systems—A Simple Issue?
por: Frommeyer, Gerrit, et al.
Publicado: (2016)

A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome – The SAlzburg MYocarditis (SAMY) Score
por: Mirna, Moritz, et al.
Publicado: (2022)

Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis
por: Mirna, Moritz, et al.
Publicado: (2022)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
por: Boxhammer, Elke, et al.
Publicado: (2022)

Case report: Short-long-short mechanism triggering sustained ventricular tachycardia in a patient with a single-chamber ICD but inhibiting antitachycardia therapy
por: Schernthaner, Christiana, et al.
Publicado: (2022)

Tei Index Complements Conventional Echocardiographic Parameters in Diagnostic Workup of Suspected Takotsubo Syndrome
por: Mirna, Moritz, et al.
Publicado: (2022)

Deactivation of implantable cardioverter-defibrillators
por: Wan, Darryl, et al.
Publicado: (2021)

Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
por: Begisbayev, Temirkhan, et al.
Publicado: (2022)

The subcutaneous implantable cardioverter-defibrillator should be considered for all patients with an implantable cardioverter-defibrillator indication
por: Tan, Jian Liang, et al.
Publicado: (2022)

Predictors of early mortality in implantable cardioverter-defibrillator recipients
por: Stein, Kenneth M., et al.
Publicado: (2009)

Subcutaneous implantable cardioverter-defibrillator placement in a patient with a preexisting transvenous implantable cardioverter-defibrillator
por: Jazayeri, Mohammad-Ali, et al.
Publicado: (2017)

Relation of multicenter automatic defibrillator implantation trial implantable cardioverter-defibrillator score with long-term cardiovascular events in patients with implantable cardioverter-defibrillator
por: Uslu, Abdulkadir, et al.
Publicado: (2018)

Remote Monitoring of Implantable Cardioverter Defibrillator
por: Reynolds, Dwight W, et al.
Publicado: (2006)

The Subcutaneous Implantable Cardioverter-Defibrillator: Not For All
por: Nair, Krishnakumar, et al.
Publicado: (2014)

Programming implantable cardioverter/defibrillators and outcomes
por: Horlbeck, Fritz W., et al.
Publicado: (2015)

Implantable cardioverter–defibrillator in hypertrophic cardiomyopathy
por: Sanchez, Diego Jimenez, et al.
Publicado: (2018)

Characteristics of Cardiac Memory in Patients with Implanted Cardioverter-defibrillators: The Cardiac Memory with Implantable Cardioverter-defibrillator (CAMI) Study
por: Haq, Kazi T., et al.
Publicado: (2021)

From Streptococcal Pharyngitis/Tonsillitis to Myocarditis: A Systematic Review
por: Schmutzler, Lukas, et al.
Publicado: (2022)

MicroRNAs in Inflammatory Heart Diseases and Sepsis-Induced Cardiac Dysfunction: A Potential Scope for the Future?
por: Mirna, Moritz, et al.
Publicado: (2019)

Defibrillation Testing of the Implantable Cardioverter Defibrillator: When, How, and by Whom?
por: Pires, Luis A
Publicado: (2007)

Predictors of Elevated Defibrillation Threshold with the Subcutaneous Implantable Cardioverter-defibrillator
por: Do, Khuyen, et al.
Publicado: (2017)

Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Systematic Review of Non-Invasive Ways of Risk Stratification, Especially in Patients Undergoing Transcatheter Aortic Valve Replacement
por: Boxhammer, Elke, et al.
Publicado: (2022)

A sustained ventricular tachycardia overlooked by subcutaneous implantable cardioverter-defibrillator but recognized by co-implanted transvenous implantable cardioverter defibrillator
por: Goto, Kentaro, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8uibkrrkvs8bam4qcag39bmjv5